Literature DB >> 25622186

A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2).

Xiaofang Hu1, Yan Cao, Yiming Meng, Mingxiao Hou.   

Abstract

IL-2 is a pleiotropic cytokine produced by T cell after antigen activation of T cell and it is so called T cell growth factor. A large number of documents suggest that Il-2 plays pivotal roles in the immune response and now Il-2 is an approved drug being used for various kinds of diseases such as cancer and dermatitis. (1) The aim of present exploration was to look at effect of IL-2 on structural, phenotypic and functional maturation of murine BMDCs. The structural and phenotypic maturation of BMDCs under influence of IL-2 were evaluated by light microscope and flow cytometry (FCM). The functional maturation of BMDCs was confirmed by cytochemistry assay, FITC-dextran, acid phosphatase (ACP) activity, bio-assay and enzyme linked immunosorbent assay (ELISA).We elucidated that IL-2 up-regulated the expression of key surface markers such as: CD80, CD83, CD86, CD40 and MHC II molecules on BMDCs, down-regulated phagocytosis activity, induced more production of IL-12 and TNF-α secreted by BMDCs. Therefore it can be concluded that IL-2 effectively enhance the maturation of BMDCs. Our results provide direct evidence to support IL-2 would be used as a potent adjuvant in preparation of DC-based vaccines, as well as an immune remedy for cancer situation.

Entities:  

Keywords:  ACP, Acidic phosphatase; APCs, LPS; BMDCs, Bone marrow derived dendritic cells; Bone marrow derived dendritic cells; CTL, Cytotoxic lymphocyte; DAB 3 3′-diaminobenzidine; FCM, Fow cytometry; IL-2, Interlukin-2; Interlukin-2; Lipopolysaccharide; MACS, Magnetic activated cell sorting; MTT 3-(4 5-Dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide; TEM, Transmission electron microscopy; maturation; surface molecules

Mesh:

Substances:

Year:  2015        PMID: 25622186      PMCID: PMC4514260          DOI: 10.1080/21645515.2015.1009336

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  38 in total

1.  Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma?

Authors:  George Philips; Michael B Atkins
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

2.  Expression of functional IL-2 receptors on mature splenic dendritic cells.

Authors:  T Fukao; S Koyasu
Journal:  Eur J Immunol       Date:  2000-05       Impact factor: 5.532

3.  Heterogeneity of human T-cell growth factor(s) due to variable glycosylation.

Authors:  R J Robb; K A Smith
Journal:  Mol Immunol       Date:  1981-12       Impact factor: 4.407

4.  Preparation of mouse bone marrow-derived dendritic cells with immunoregulatory properties.

Authors:  Mercedes Segovia; Maria Cristina Cuturi; Marcelo Hill
Journal:  Methods Mol Biol       Date:  2011

5.  Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs).

Authors:  Yiming Meng; Qiushi Wang; Zhenjie Zhang; Enhua Wang; Nicollas P Plotnikoff; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2013-03-07       Impact factor: 3.452

6.  Reduction of myeloid suppressor cell derived nitric oxide provides a mechanistic basis of lead enhancement of alloreactive CD4(+) T cell proliferation.

Authors:  David G Farrer; Sara Hueber; Michael D Laiosa; Kevin G Eckles; Michael J McCabe
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-22       Impact factor: 4.219

7.  The adipocytokine resistin stimulates the production of proinflammatory cytokines TNF-α and IL-6 in pancreatic acinar cells via NF-κB activation.

Authors:  C Y Jiang; W Wang; J X Tang; Z R Yuan
Journal:  J Endocrinol Invest       Date:  2013-06-10       Impact factor: 4.256

8.  Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.

Authors:  Sojan Abraham; Rajendra Pahwa; Chunting Ye; Jang-Gi Choi; Savita Pahwa; Shashidhar Jaggaiahgari; Ashwin Raut; Shuiping Chen; N Manjunath; Premlata Shankar
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Fusions between dendritic cells and whole tumor cells as anticancer vaccines.

Authors:  Shigeo Koido; Sadamu Homma; Masato Okamoto; Yoshihisa Namiki; Kazuki Takakura; Kan Uchiyama; Mikio Kajihara; Seiji Arihiro; Hiroo Imazu; Hiroshi Arakawa; Shin Kan; Hideo Komita; Masaki Ito; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

10.  Autologous immune enhancement therapy: A case report of a stage IV colonic cancer.

Authors:  Baskar Subramani; Kananathan Ratnavelu; Chithra Ramanathan Pullai; Kohila Krishnan; Sheela Devi Sugadan; Xuewen Deng; Terunuma Hiroshi
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

View more
  2 in total

1.  Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12.

Authors:  Zhi Guo; Hong-Yan Gao; Tian-Yang Zhang; Jin-Xing Lou; Kai Yang; Xiao-Dong Liu; Xue-Peng He; Hui-Ren Chen
Journal:  Biomed Rep       Date:  2016-10-06

2.  Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis.

Authors:  Yong Zhang; Mingfeng Guo; Ning Xin; Zhen Shao; Xiuying Zhang; Yanyan Zhang; Jing Chen; Shuangshuang Zheng; Linlin Fu; YuZhong Wang; Dongmei Zhou; Hao Chen; Yan Huang; Ruiguo Dong; Chenghua Xiao; Yonghai Liu; Deqin Geng
Journal:  Clin Exp Med       Date:  2015-05-12       Impact factor: 3.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.